The objective of this webinar is to provide participants with an update on the assessment and the management of coagulopathy associated with COVID–19.

The live webinar was held on Monday, March 29, 2021.

Click on the link below to view the on-demand version.

View the on-demand webinar


Chairs: Jens Meier, Linz, Austria
Marco Ranucci, Milan, Italy

Welcome and introduction
Jens Meier, Linz, Austria

Pathophysiology of COVID–19-induced coagulopathy
Jecko Thachil, Manchester, UK

Haemostatic monitoring in COVID–19 patients: laboratory tests and viscoelastic assays
Mauro Panigada, Milan, Italy

Management of coagulopathy in COVID–19 patients: what is current guidance?
Saskia Middeldorp, Nijmegen, The Netherlands

Interactive panel discussion
All faculty

Concluding comments
Marco Ranucci, Milan, Italy

Educational objectives

After completing this educational activity, learners should be able to:

CME accreditation

The programme has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 1 European CME credit (ECMEC®).

Each medical specialist should claim only those credits that he/she actually spent in the educational activity.

The EACCME® is an institution of the European Union of Medical Specialists (UEMS),

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME® credits to AMA credits can be found at

Live educational activities occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC® credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.


This webinar is supported by an unrestricted educational grant from Haemonetics.